305 related articles for article (PubMed ID: 32425013)
1. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
Boccia M; Aronne L; Celia B; Mazzeo G; Ceparano M; D'Agnano V; Parrella R; Valente T; Bianco A; Perrotta F
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425013
[TBL] [Abstract][Full Text] [Related]
2. [Coagulopathy and COVID-19. Recommendations for a changing reality].
Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
[TBL] [Abstract][Full Text] [Related]
3. The unique characteristics of COVID-19 coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
6. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
7. Coagulation Dysfunction.
Fei Y; Tang N; Liu H; Cao W
Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
10. Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
Pawlowski C; Wagner T; Puranik A; Murugadoss K; Loscalzo L; Venkatakrishnan AJ; Pruthi RK; Houghton DE; O'Horo JC; Morice WG; Williams AW; Gores GJ; Halamka J; Badley AD; Barnathan ES; Makimura H; Khan N; Soundararajan V
Elife; 2020 Aug; 9():. PubMed ID: 32804081
[TBL] [Abstract][Full Text] [Related]
11. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
Zadow EK; Wundersitz DWT; Hughes DL; Adams MJ; Kingsley MIC; Blacklock HA; Wu SSX; Benson AC; Dutheil F; Gordon BA
Semin Thromb Hemost; 2020 Oct; 46(7):807-814. PubMed ID: 32882720
[TBL] [Abstract][Full Text] [Related]
13. Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.
Masi P; Hékimian G; Lejeune M; Chommeloux J; Desnos C; Pineton De Chambrun M; Martin-Toutain I; Nieszkowska A; Lebreton G; Bréchot N; Schmidt M; Edouard Luyt C; Combes A; Frere C
Circulation; 2020 Aug; 142(6):611-614. PubMed ID: 32776849
[No Abstract] [Full Text] [Related]
14. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
Amgalan A; Othman M
Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis.
Jin S; Jin Y; Xu B; Hong J; Yang X
Thromb Haemost; 2020 Nov; 120(11):1524-1535. PubMed ID: 32679593
[TBL] [Abstract][Full Text] [Related]
16. [Dealing with COVID-19-associated coagulopathy].
Klok FA; den Exter PL; Huisman MV; Eikenboom J
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
[TBL] [Abstract][Full Text] [Related]
17. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
[TBL] [Abstract][Full Text] [Related]
18. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.
Zhang Y; He L; Chen H; Lu S; Xiong Y; Liu J; Zheng Y; Wang S; Liu L
Int J Lab Hematol; 2020 Dec; 42(6):766-772. PubMed ID: 32592539
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
[No Abstract] [Full Text] [Related]
20. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
Ornelas-Ricardo D; Jaloma-Cruz AR
Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
